Skip NavigationSkip to Content

Modifications in an Emergency: The Role of N1-Methylpseudouridine in COVID-19 Vaccines

  1. Author:
    Nance,Kellie
    Meier,Jordan
  2. Author Address

    NCI, Chem Biol Lab, Ctr Canc Res, NIH, Frederick, MD 21702 USA.
    1. Year: 2021
    2. Date: May 26
    3. Epub Date: 2021 04 06
  1. Journal: ACS central science
  2. AMER CHEMICAL SOC,
    1. 7
    2. 5
    3. Pages: 748-756
  3. Type of Article: Review
  4. ISSN: 2374-7943
  1. Abstract:

    The novel coronavirus SARS-CoV-2, the cause of the COVID-19 pandemic, has inspired one of the most efficient vaccine development campaigns in human history. A key aspect of COVID-19 mRNA vaccines is the use of the modified nucleobase N1-methylpseudouridine (m1 Psi) to increase their effectiveness. In this Outlook, we summarize the development and function of m1 Psi in synthetic mRNAs. By demystifying how a novel element within these medicines works, we aim to foster understanding and highlight future opportunities for chemical innovation.

    See More

External Sources

  1. DOI: 10.1021/acscentsci.1c00197
  2. PMID: 34075344
  3. PMCID: PMC8043204
  4. WOS: 000657243600009

Library Notes

  1. Fiscal Year: FY2020-2021
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel